期刊文献+

西黄丸联合化疗治疗中晚期非小细胞肺癌临床观察 被引量:27

下载PDF
导出
摘要 目的观察西黄丸联合化疗治疗中晚期非小细胞肺癌的临床近期和2年随防疗效及毒副反应。方法患者60例随机分为治疗组与对照组各30例,对照组予单纯化疗,给长春瑞滨25mg/m2,第1、8日,顺铂80mg/m2,第1、2日,每28日为1周期,至少治疗2个周期;治疗组于对照组化疗方案基础上加用西黄丸,每次3g,每日2次。结果两组均无CR病例,对照组PR10例,SD13例,PD7例;临床受益率为40.00%;中位生存期10个月,疾病进展时间5.2个月,1年生存期为43.33%(13/30),2年生存期为16.67%(5/30),在化疗期间1例出现下肢静脉血栓形成。治疗组PR12例,SD14例,PD4例;临床受益率46.67%;中位生存期11个月,疾病进展时间6.8个月,1年生存期为50.00%(15/30),2年生存期为26.67%(8/30),两组比较差异有显著性。结论西黄丸联合化疗疗效优于单纯化疗,能够提高1年生存期,减轻化疗副作用。
出处 《中国中医急症》 2008年第1期22-23,共2页 Journal of Emergency in Traditional Chinese Medicine
  • 相关文献

参考文献2

二级参考文献14

  • 1吴一龙,蒋国梁,廖美琳,王绿化,周清华,杨学宁,孙燕,无.局部晚期非小细胞肺癌化放疗共识[J].循证医学,2005,5(3):186-188. 被引量:36
  • 2Furuse K,Fukuoka M,Kawahara M,et al.Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin,vinblastine and cisplatine in unresectable stage Ⅲ non-small cell lung cancer[J].J Clin Oncol,1999,17:2692-2699.
  • 3Curran W,Scott C,Langer C,et al.Phase Ⅲ comparison of sequential vs.concurrent chemoradiation of pts with unresected stage Ⅲ non-small cell lung cancer (NSCLC):initial report of Radiation Therapy Oncology Group (RTOG) 9410[C].Proc.Am Soc Clin Oncol,2000,Abstract 1891.
  • 4Albain K,Rusch VW,Crowley JJ,et al.Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage ⅢA (N2) and ⅢB non-small cell lung cancer:mature results of Southwest Oncology Group phase Ⅱ study 8805[J].J Clin Oncol,1995,13:1880-1892.
  • 5Albain KS,Scott CB,Rusch VR,et al.Phase Ⅲ comparision of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage ⅢA(PN2) non-small cell lung cancer (NSCLC):Initial results from intergroup trial 0139(RTOC 93-09)[C].Proc Am Soc Clin Oncol,2003,Abstract 2497.
  • 6Vokes EE,Derndon JE,Kelly MJ,et al.Induction chemotherapy followed by concurrent chemoradiotherapy(CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell cancer:Initial analysis of a randomized phase 3 trial[C].Proc Am Soc Clin Oncol,2004,Abstract 7005.
  • 7Huber RM,Flentje M,Gosse H,et al.Induction chemotherapy and following simultaneous radiochemotherapy versus induction chemotherapy and radiotherapy alone in inoperable NSCLC(stage ⅢA/ⅢB):Update of CT/RT 99/97[C].Proc Am Soc Clin Oncol,2004,Abstract 7075.
  • 8Cater DL,Keller AM,Tolley RC,et al.A randomized phase Ⅲ trial of combined paclitaxel,carboplatin,and radiation therapy folled by either weekly paclitaxel observation in patients with stage Ⅲ non-small cell lung cancer[C].Proc Am Soc Clin Oncol,2004,Abstract 7076.
  • 9Kelly K,Gaspar LE,Chansky K et al.Low incidence of pneumonitis on SWOG 0023:A preliminary analysis of an onging phase 3 trial of concurrent chemoradiotherapy followed by consolidation docetaxel and gefitinib/placebo maintenance in patients with inoperable stage 3 non-small cell lung cancer[C].Proc Am Soc Clin Oncol,2005,Abstract 7058.
  • 10Gandara DR,Chansky K,Gaspar LE,et al.Long term survival in stage 3b non-small cell lung cancer (NSCLC) treatment with consolidation docetaxel following concurrent chemoradiotherapy (SWOGS 9504)[C].Proc Am Soc Clin Oncol,2005,Abstract 7059.

共引文献35

同被引文献332

引证文献27

二级引证文献247

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部